Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark Jackson

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Drugs in Dermatology : JDD|August 16, 2017
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL StudyBruce Strober, Jerry Bagel, Mark Lebwohl, et al.
The Journal of Dermatological Treatment|September 14, 2007
Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) studyAlice B Gottlieb, Leon Kircik, Drore Eisen, et al.
Journal of Drugs in Dermatology : JDD|January 22, 2015
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trialsLinda Stein Gold, Leon Kircik, Joseph Fowler, et al.
Journal of the American Academy of Dermatology|June 1, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosaceaMartin Schaller, Lajos Kemény, Blanka Havlickova, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2007
Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trialAlexa Boer Kimball, J Mark Jackson, Jeffrey M Sobell, et al.
Journal of Drugs in Dermatology : JDD|January 22, 2015
Optimizing the use of topical brimonidine in rosacea management: panel recommendationsEmil A Tanghetti, J Mark Jackson, Kevin Tate Belasco, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Drugs in Dermatology : JDD|August 16, 2017
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL StudyBruce Strober, Jerry Bagel, Mark Lebwohl, et al.
The Journal of Dermatological Treatment|September 14, 2007
Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) studyAlice B Gottlieb, Leon Kircik, Drore Eisen, et al.
Journal of Drugs in Dermatology : JDD|January 22, 2015
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trialsLinda Stein Gold, Leon Kircik, Joseph Fowler, et al.
Journal of the American Academy of Dermatology|June 1, 2019
A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosaceaMartin Schaller, Lajos Kemény, Blanka Havlickova, et al.
Journal of Drugs in Dermatology : JDD|March 22, 2007
Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trialAlexa Boer Kimball, J Mark Jackson, Jeffrey M Sobell, et al.
Journal of Drugs in Dermatology : JDD|January 22, 2015
Optimizing the use of topical brimonidine in rosacea management: panel recommendationsEmil A Tanghetti, J Mark Jackson, Kevin Tate Belasco, et al.
Pageof 4